Bioiberica presented Condrovet® Force HA, Impromune and Atopivet in Portugal
The 14th meeting of the Montenegro Veterinary Hospital, held on 24-25 February 2018, was attended by more than 3,000 visitors
The latest Bioiberica product for joint care in cats and dogs, Condrovet® Force HA, raised great interest at the annual meeting hosted by the Montenegro Veterinary Hospital. This meeting was held on 24-25 February 2018 at the Europarque venue in Santa Maria da Feira (Portugal). Hundreds of veterinarians visited Bioiberica’s booth to learn more about our new chondroprotector that includes exclusive ingredients such as Mobilee®, b-2Cool® and CS b-Bioactive®. It has the potential to be the most complete therapeutic tool for the treatment of canine and feline osteoarthritis, as well as for the management of degenerative conditions of the joint cartilage caused by age, being overweight or excessive exercise.
Our booth also presented Atopivet® capsules, our treatment for dogs with atopic dermatitis, and clinical trials on the use of Impromune in leishmaniasis.
This year’s congress was attended by more than 3,000 visitors and 34 renowned international speakers. It was sponsored by leading firms within the veterinary sector such as Bioiberica.
Related News
- This marks yet another step forward in the internalisation strategy of this business unit's dedicated to companion animal health
- The company has launched three products for joint and internal health: Condrovet® Force HA, Calmurofel® and Impromune®
- The study, carried out at the University of Florida, supports the use of this new formulation of sphingolipids and glycosaminoglycans as a strategy to improve skin health in patients with canine atopic dermatitis
- The fourth Iberzoo Propet will be held from 5 to 7 March at the Feria de Madrid
- Klorexivet®, Prolivet® and Condrovet Force HA® are scientifically proven products that bring value added for veterinarians